Literature DB >> 6520832

The lupus activity criteria count (LACC).

M B Urowitz, D D Gladman, E C Tozman, C H Goldsmith.   

Abstract

A single clinical and laboratory assessment from each of 50 randomly chosen patients with systemic lupus erythematosus followed in a prospective study were evaluated for disease activity by 3 individual rheumatologists. Of the 50 assessments, 24 were considered to be active, 12 possibly active and 14 inactive. The 38 assessments that were clearly active or inactive were then analyzed. Clusters of variables were chosen for clinical relevance and association with activity, and 7 highly associated variables were combined into the lupus activity criteria count. Analysis of these criteria in the 50 assessments revealed that the presence of any 2 correctly predicted active disease in 100% of cases. This activity criteria count was then validated using a second sample of 50 assessments.

Entities:  

Mesh:

Year:  1984        PMID: 6520832

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  35 in total

1.  Correlation of serum prolactin levels and disease activity in systematic lupus erythematosus.

Authors:  Mansoor Karimifar; Afshin Tahmasebi; Zahra Sayed Bonakdar; Samaneh Purajam
Journal:  Rheumatol Int       Date:  2011-11-08       Impact factor: 2.631

2.  Diastolic impairment in asymptomatic systemic lupus erythematosus patients.

Authors:  E Astorri; P Fiorina; G A Contini; D Albertini; E Ridolo; P Dall'Aglio
Journal:  Clin Rheumatol       Date:  1997-05       Impact factor: 2.980

3.  Analysis of autoantibodies to plasminogen in the serum of patients with rheumatoid arthritis.

Authors:  M Gonzalez-Gronow; M Cuchacovich; D M Grigg; S V Pizzo
Journal:  J Mol Med (Berl)       Date:  1996-08       Impact factor: 4.599

Review 4.  A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis.

Authors:  Andrew Smyth; Guilherme H M Oliveira; Brian D Lahr; Kent R Bailey; Suzanne M Norby; Vesna D Garovic
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 8.237

5.  Peripheral vascular disease in patients with systemic lupus erythematosus.

Authors:  J McDonald; J Stewart; M B Urowitz; D D Gladman
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

6.  Antibodies to histones in systemic lupus erythematosus: prevalence, specificity, and relationship to clinical and laboratory features.

Authors:  M G Cohen; K M Pollard; J Webb
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

7.  A long-term immunological study of childhood onset systemic lupus erythematosus.

Authors:  C K Ting; K H Hsieh
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

8.  Expression of MHC class I determinants on erythrocytes of SLE patients.

Authors:  C M Giles; M J Walport; J David; C Darke
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

9.  Lymphadenopathy in systemic lupus erythematosus. Prevalence and relation to disease manifestations.

Authors:  Y Shapira; A Weinberger; A J Wysenbeek
Journal:  Clin Rheumatol       Date:  1996-07       Impact factor: 2.980

10.  Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus.

Authors:  A A Long; S D Denburg; R M Carbotte; D P Singal; J A Denburg
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.